The Chemours Company (CC)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The Chemours Company (CC) is up 86.2% since the beginning of the year. At $22 per share, CC is trading 24.1% below its 52-week high of $29. Investors who bought $1,000 worth of CC shares 5 years ago would now be looking at an investment worth $784.

The Chemours Company (CC) has returned 86.24% so far this year and 102.22% over the past 12 months. Over the last ten years, CC has returned 12.60% per year, falling short of the S&P 500 Index benchmark, which averaged 13.67% annually.

Based on dividend-adjusted daily data since Jul 1, 2015, CC's average daily return is +0.10%, while the average monthly return is +2.02%. At this rate, an investment would double in approximately 2.9 years.

Historically, 52% of months were positive and 48% were negative. The best month was Nov 2016 with a return of +50.7%, while the worst month was May 2019 at -40.8%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 5 months.

On a daily basis, CC closed higher 50% of trading days. The best single day was Dec 18, 2015 with a return of +26.3%, while the worst single day was Feb 29, 2024 at -31.5%.

The Chemours Company has an annualized alpha of 2.33%, beta of 1.71, and R2 of 0.25 versus S&P 500 Index. Calculated based on daily prices since July 01, 2015.

• This stock participated in 168.30% of S&P 500 Index downside but only 156.39% of its upside - more exposed to losses than it benefited from rallies.
• R2 of 0.25 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

CC ranks 80 for risk / return — in the top 80% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The Chemours Company provided a 1.61% dividend yield over the last twelve months, with an annual payout of $0.35 per share.

The table displays the monthly dividend distributions for The Chemours Company. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the The Chemours Company. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the The Chemours Company was 86.15%, occurring on Apr 3, 2020. The portfolio has not yet recovered.

The current The Chemours Company drawdown is 47.65%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of The Chemours Company over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how The Chemours Company is priced in the market compared to other companies in the Specialty Chemicals industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.